Ignite Creation Date:
2024-05-05 @ 5:03 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00372294
Status:
UNKNOWN
Last Update Posted:
2008-07-30
First Post:
2006-09-05
Brief Title:
To Compare Intravitreal Clindamycin Dexamethasone With Classic Treatment of Toxoplasmic Retinochoroiditis
Sponsor:
Shahid Beheshti University of Medical Sciences
Organization:
Shahid Beheshti University of Medical Sciences
Study Overview
Official Title:
None
Status:
UNKNOWN
Status Verified Date:
2008-06
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Toxoplasmosis an intra cellular parasite is a very important cause of chorioretinitis The goal of treatment is arresting multiplication of the parasite in its inflammatory active phase In this study the investigators try to compare the efficacy of the classic regimen Pyrimethamine-Sulfadiazine Prednisolon with intravitreal Clindamycin Dexamethasone
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None